Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer

DSpace Repository

Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer

Author: Stratmann, Jan A.; Michels, Sebastian; Hornetz, Sofia; Christoph, Daniel C.; Sackmann, Sandra; Spengler, Werner; Bischoff, Helge; Schaefer, Monica; Alt, Juergen; Mueller, Annette; Laack, Eckart; Kimmich, Martin; Griesinger, Frank; Sebastian, Martin
Tübinger Autor(en):
Spengler, Werner
Published in: Journal of Cancer Research and Clinical Oncology (2018), Bd. 144, H. 12, S. 2457-2463
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00432-018-2754-x
ISSN: 1432-1335
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)